-52.9%
NVO vs BBIO
+154.4%
-207.4%
-74.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.1% | -0.1% | -2.1% | -2.1% |
| 7D | -7.6% | -3.2% | -4.4% | -7.2% |
| 30D | -6.0% | -13.6% | +7.6% | -4.2% |
| 3M | -0.8% | +7.2% | -8.0% | -2.0% |
| 6M | +16.5% | +1.5% | +15.0% | +15.7% |
| YTD | -11.1% | -5.3% | -5.8% | -11.3% |
| 1Y | -16.7% | +37.7% | -54.4% | -20.0% |
| 3Y | -52.9% | +153.9% | -206.8% | -58.3% |
| All | -52.9% | +154.4% | -207.4% | -58.3% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling